Short bowel syndrome related intestinal failure outcomes in Latin America: Insights from the RESTORE Registry.
Latin America
intestinal failure
parenteral nutrition
registry
short bowel syndrome
Journal
JPEN. Journal of parenteral and enteral nutrition
ISSN: 1941-2444
Titre abrégé: JPEN J Parenter Enteral Nutr
Pays: United States
ID NLM: 7804134
Informations de publication
Date de publication:
05 Oct 2024
05 Oct 2024
Historique:
revised:
16
09
2024
received:
14
05
2024
accepted:
17
09
2024
medline:
6
10
2024
pubmed:
6
10
2024
entrez:
5
10
2024
Statut:
aheadofprint
Résumé
Short bowel syndrome is considered a low prevalence disease. The scant information available about intestinal failure in Latin America was the driving force to expand this registry. A prospective, multicenter observational registry was created for patients with chronic intestinal failure short bowel at specialized centers in Latin America. Demographics, clinical characteristics, nutrition assessment, parenteral nutrition management, intestinal rehabilitation, related complications, clinical outcome, and survival were analyzed. From May 2020 to July 2023, 167 patients (115 adults, 52 children) from 20 centers were enrolled. For the adults, the mean age was 37.2 ± 18 years, 48% were female, and the mean follow-up was 22.6 ± 18.3 months. The main etiology was surgical resections (postsurgical complications: 37%; ischemia: 25%); the mean intestinal length was 73 ± 55 cm. The complications were as follows: infections: 0.4/1000 catheter-days; thrombosis: 0.24/1000 catheter-days; liver disease: 2.6%. The outcomes were as follows: 28% were rehabilitated, 15% died, 9.6% were lost to follow-up, 0.9% underwent transplant, and 45.6% continued follow-up. For the children, the mean age 48 ± 52 months, 48% were female, 52% were premature. The mean follow-up was 17.2 ± 5.6 months; the mean remaining intestinal length was 38 ± 45 cm. The leading etiologies were atresia (25%), NEC (23%), and gastroschisis (21%). The complication were as follows: infections: 2/1000 catheter-days; thrombosis: 2.22/1000 catheter-day; 25% developed liver disease. The outcomes were as follows: 7.7% died, 3.8% were rehabilitated, and 88.5% continued follow-up. The RESTORE amendment served as a registry and educational tool for the participating teams. The aspiration is to objectively show current aspects of intestinal failure in the region and carry them to international standards. Including all Latin American countries and etiologies of chronic intestinal failure besides short gut would serve to complete this registry.
Sections du résumé
BACKGROUND
BACKGROUND
Short bowel syndrome is considered a low prevalence disease. The scant information available about intestinal failure in Latin America was the driving force to expand this registry.
METHODS
METHODS
A prospective, multicenter observational registry was created for patients with chronic intestinal failure short bowel at specialized centers in Latin America. Demographics, clinical characteristics, nutrition assessment, parenteral nutrition management, intestinal rehabilitation, related complications, clinical outcome, and survival were analyzed.
RESULTS
RESULTS
From May 2020 to July 2023, 167 patients (115 adults, 52 children) from 20 centers were enrolled. For the adults, the mean age was 37.2 ± 18 years, 48% were female, and the mean follow-up was 22.6 ± 18.3 months. The main etiology was surgical resections (postsurgical complications: 37%; ischemia: 25%); the mean intestinal length was 73 ± 55 cm. The complications were as follows: infections: 0.4/1000 catheter-days; thrombosis: 0.24/1000 catheter-days; liver disease: 2.6%. The outcomes were as follows: 28% were rehabilitated, 15% died, 9.6% were lost to follow-up, 0.9% underwent transplant, and 45.6% continued follow-up. For the children, the mean age 48 ± 52 months, 48% were female, 52% were premature. The mean follow-up was 17.2 ± 5.6 months; the mean remaining intestinal length was 38 ± 45 cm. The leading etiologies were atresia (25%), NEC (23%), and gastroschisis (21%). The complication were as follows: infections: 2/1000 catheter-days; thrombosis: 2.22/1000 catheter-day; 25% developed liver disease. The outcomes were as follows: 7.7% died, 3.8% were rehabilitated, and 88.5% continued follow-up.
CONCLUSION
CONCLUSIONS
The RESTORE amendment served as a registry and educational tool for the participating teams. The aspiration is to objectively show current aspects of intestinal failure in the region and carry them to international standards. Including all Latin American countries and etiologies of chronic intestinal failure besides short gut would serve to complete this registry.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 American Society for Parenteral and Enteral Nutrition.
Références
Goulet O, Ruemmele F, Lacaille F, Colomb V. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr. 2004;38:250‐269.
O'Keefe SJD, Buchman AL, Fishbein TM, Jeejeebhoy KN, Jeppesen PB, Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006;4:6‐10.
Norsa L, Goulet O, Alberti D, et al. Nutrition and intestinal rehabilitation of children with short bowel syndrome: a position paper of the ESPGHAN Committee on nutrition. Part 1: From tntestinal resection to home discharge. J Pediatr Gastroenterol Nutr. 2023;77:281‐297.
Norsa L, Goulet O, Alberti D, et al. Nutrition and intestinal rehabilitation of children with short bowel syndrome: a position paper of the ESPGHAN Committee on Nutrition. Part 2: Long‐term follow‐up on home parenteral nutrition. J Pediatr Gastroenterol Nutr. 2023;77:298‐314.
Sigalet DL. Advances in glucagon like peptide‐2 therapy, physiology, current indications and future directions. Semin Pediatr Surg. 2018;27:237‐241.
Furtado S, Ahmed N, Forget S, Sant'Anna A. Outcomes of patients with intestinal failure after the development and implementation of a multidisciplinary team. Can J Gastroenterol Hepatol. 2016;2016:1‐6.
Javid PJ, Wendel D, Horslen SP. Organization and outcomes of multidisciplinary intestinal failure teams. Semin Pediatr Surg. 2018;27:218‐222.
Kaufman SS, Avitzur Y, Beath SV, et al. New insights into the indications for intestinal transplantation: consensus in the year 2019. Transplantation. 2020;104:937‐946.
Raghu VK, Rumbo C, Horslen SP. From intestinal failure to transplantation: review on the current need for transplant indications under multidisciplinary transplant programs worldwide. Pediatr Tranplant. 2024;28:e14756.
Gondolesi GE, Pattín F, Nikkoupur H. Management of intestinal failure in middle‐income countries, for children and adults. Curr Opin Organ Transplant. 2018;23:212‐218.
Gondolesi GE, Ortega ML, Doeyo M, et al. First registry of adult patients with chronic intestinal failure due to short bowel syndrome in Argentina: The RESTORE project. JPEN J Parenter Enteral Nutr. 2022;46:1623‐1631.
Pironi L. Definition, classification, and causes of short bowel syndrome. Nutr Clin Pract. 2023;38(suppl 1):S9‐S16.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205‐213.
Centers for Disease Control and Prevention. Central line associated bloodstream infection and non‐central line‐associated bloodstream infection. Accessed April 4, 2024. https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf
Lacaille F, Gupte G, Colomb V, et al. Intestinal failure‐associated liver disease: a position paper of the ESPGHAN Working Group of intestinal failure and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2015;60:272‐283.
Neelis EG, Roskott AM, Dijkstra G, et al. Presentation of a nationwide multicenter registry of intestinal failure and intestinal transplantation. Clin Nutr. 2016;35:225‐229.
Naghibi M, Toskas A, Willsmore J, Smith T, Hughes SJ, Gabe S. United Kingdom artificial nutrition database: the changing landscape of adult home parenteral support. JPEN J Parenter Enteral Nutr. 2023;47:635‐645.
Avitzur Y, Pahl E, Venick R. The development of the international intestinal failure registry and an overview of its results. Eur J Pediatr Surg. 2024;34:172‐181.
Mundi MS, Mercer DF, Iyer K, et al. Characteristics of chronic intestinal failure in the USA based on analysis of claims data. JPEN J Parenter Enteral Nutr. 2022;46:1614‐1622.
Smith T, Naghibi M. BANS Report 2016: Artificial Nutrition Support in the UK 2005–2015. Adult Home Parenteral Nutrition & Home Intravenous Fluids. British Artificial Nutrition Survey; 2017. https://www.bapen.org.uk/images/pdfs/reports/bans-report-2016.pdf
Wanden‐Berghe C, Virgili Casas N, Cuerda Compés C, et al. Home and ambulatory artificial nutrition (NADYA) Group report: home parenteral nutrition in Spain, 2019. Nutr Hosp. 2021;38:1304‐1309.
Goulet O, Lambe C. Intravenous lipid emulsions in pediatric patients with intestinal failure. Curr Opin Organ Transplant. 2017;22:142‐148.
Lloyd DAJ, Vega R, Bassett P, Forbes A, Gabe SM. Survival and dependence on home parenteral nutrition: experience over a 25‐year period in a UK referral centre. Aliment Pharmacol Ther. 2006;24:1231‐1240.
Pironi L, Paganelli F, Labate AMM, et al. Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16‐year experience at a single centre. Dig Liver Dis. 2003;35:314‐324.
Fuglsang KA, Brandt CF, Scheike T, Jeppesen PB. Hospitalizations in patients with nonmalignant short‐bowel syndrome receiving home parenteral support. Nutr Clin Pract. 2020;35:894‐902.
Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35:247‐307.
Crooks B, Harrison S, Millward G, et al. Catheter‐related infection rates in patients receiving customized home parenteral nutrition compared with multichamber bags. JPEN J Parenter Enteral Nutr. 2022;46:254‐257.
Crivelli A, Fabeiro M, Puga M, et al. Care of patients on home parenteral nutrition during the first year of the COVID‐19 pandemic: management of central line‐associated bloodstream infections. Clin Nutr ESPEN. 2022;52:250‐253.
Cuerda C, Joly F, Corcos O, et al. Prospective study of catheter‐related central vein thrombosis in home parenteral nutrition patients with benign disease using serial venous Doppler ultrasound. Clin Nutr. 2016;35:153‐157.
Puoti MG, D'Eusebio C, Littlechild H, King E, Koeglmeier J, Hill S. Risk factors for catheter‐related bloodstream infections associated with home parental nutrition in children with intestinal failure: a prospective cohort study. Clin Nutr. 2023;42:2241‐2248.
Goulet O, Breton A, Coste ME, et al. Pediatric home parenteral nutrition in France: a six years national survey. Clin Nutr. 2021;40:5278‐5287.
Puntis JW, Holden CE, Smallman S, Finkel Y, George RH, Booth IW. Staff training: a key factor in reducing intravascular catheter sepsis. Arch Dis Child. 1991;66:335‐337.
Böll B, Schalk E, Buchheidt D, et al. Central venous catheter‐related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2021;100:239‐259.
Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M. ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr. 2009;28:365‐377.
van den Bosch CH, Jeremiasse B, van der Bruggen JT, et al. The efficacy of taurolidine containing lock solutions for the prevention of central‐venous‐catheter‐related bloodstream infections: a systematic review and meta‐analysis. J Hosp Infect. 2022;123:143‐155.
Tribler S, Brandt CF, Petersen AH, et al. Taurolidine‐citrate‐heparin lock reduces catheter‐related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo‐controlled trial. Am J Clin Nutr. 2017;106:839‐848.
Zapata Olivares Y, Hodgson Bunster MI, Cordero Bayón ML, Rodríguez Osiac L, Cerda Lorca J. Home parenteral nutrition in pediatric patients with intestinal insufficiency. Rev Chil Pediatr. 2019;90:60‐68.
Chapman B, De Cruz P, Jones R, Hardikar W, Testro A. Intestinal failure and transplant: the Australian experience (2009 to 2014). Transplant Proc. 2016;48:463‐467.
Mendez Martinez C, Ayala Acosta JC. Nutrición parenteral domiciliaria. Una necesidad en Colombia. Medicina. 2023;45:275‐283.
Martinuzzi A, Núñez A, Bogado M, et al. Experiencias de la administración de nutrición parenteral domiciliaria en pacientes atendidos por falla intestinal en el sur de la Argentina. Rev Cubana Med Trop. 2020;30:77‐90.
Spolidoro JVN, Souza MC, Goldani HAS, et al. International Latin American survey on pediatric intestinal failure team. Nutrients. 2021;13:2754.
Global Observatory on Donation and Transplantation. Global Report on Organ Donation and Transplantation. Accessed April 15, 2024. https://www.transplant-observatory.org/wp-content/uploads/2022/07/2020-Global-report-para-web.pdf
Gondolesi GE, Doeyo M, Solar‐Muñiz H. A detailed analysis of the current status of intestinal transplantation in Latin America. Curr Opin Organ Transplant. 2020;25:189‐195.
Raghu VK, Beaumont JL, Everly MJ, Venick RS, Lacaille F, Mazariegos GV. Pediatric intestinal transplantation: analysis of the intestinal transplant registry. Pediatr Tranplant. 2019;23:e13580.
Argentine Ministry of Health. International relations. Accessed April 15, 2024. https://www.argentina.gob.ar/salud/incucai/relaciones-internacionales
Fabeiro M, Dalieri M, Martínez M, et al. Home parenteral nutrition (HPN): feasibility of its implementation from a public hospital. Nutr Hosp. 2011;26:1435‐1439.
Gondolesi GE, Rumbo C, Fernández A, Mauriño E, Ruf A. Intestinal transplant. Review and description of its evolution in Latin America] Acta Gastroenterol Latinoam. 2009;39:63‐80.
Argentine Ministry of Health. Regulations for the Certification of People with Visceral Disabilities. Accessed April 3, 2024. https://www.argentina.gob.ar/normativa/nacional/disposici%C3%B3n-2574-2011-194636
Martinez LM, Rumbo C, Martinez MI, Gondolesi GE. P4.43: Evaluation of accessibility to intestinal failure therapy and transplant, in a center from an emergent economy country. Transplantation. 2019;103(7S2):S163.